Cargando…

Importance of Coverage and Endemicity on the Return of Infectious Trachoma after a Single Mass Antibiotic Distribution

BACKGROUND: As part of the SAFE strategy, mass antibiotic treatments are useful in controlling the ocular strains of chlamydia that cause trachoma. The World Health Organization recommends treating at least 80% of individuals per community. However, the role of antibiotic coverage for trachoma contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lakew, Takele, Alemayehu, Wondu, Melese, Muluken, Yi, Elizabeth, House, Jenafir I., Hong, Kevin C., Zhou, Zhaoxia, Ray, Kathryn J., Porco, Travis C., Gaynor, Bruce D., Lietman, Thomas M., Keenan, Jeremy D.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2724711/ https://www.ncbi.nlm.nih.gov/pubmed/19707573 http://dx.doi.org/10.1371/journal.pntd.0000507

Ejemplares similares

Reduction and Return of Infectious Trachoma in Severely Affected Communities in Ethiopia
por: Lakew, Takele, et al.
Publicado: (2009)

A rationale for continuing mass antibiotic distributions for trachoma
por: Ray, Kathryn J, et al.
Publicado: (2007)

Concordance of ompA types in children re-infected with ocular Chlamydia trachomatis following mass azithromycin treatment for trachoma
por: Mosenia, Arman, et al.
Publicado: (2022)

The Fitness Cost of Antibiotic Resistance in Streptococcus pneumoniae: Insight from the Field
por: Maher, M. Cyrus, et al.
Publicado: (2012)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
por: Lietman, Thomas M., et al.
Publicado: (2015)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Identifying a sufficient core group for trachoma transmission
por: Lietman, Thomas M., et al.
Publicado: (2018)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment
por: Kim, Matthew C., et al.
Publicado: (2019)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining
por: Rahman, Salman A., et al.
Publicado: (2015)

Risk Factors for Ocular Chlamydia after Three Mass Azithromycin Distributions
por: Ayele, Berhan, et al.
Publicado: (2011)

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial
por: Amza, Abdou, et al.
Publicado: (2012)

Trachoma Decline and Widespread Use of Antimicrobial Drugs
por: Chidambaram, Jaya D., et al.
Publicado: (2004)

Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination
por: Lietman, Thomas M, et al.
Publicado: (2018)

When Can Antibiotic Treatments for Trachoma Be Discontinued? Graduating Communities in Three African Countries
por: Ray, Kathryn J., et al.
Publicado: (2009)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2015)

Application of smartphone cameras for detecting clinically active trachoma
por: Bhosai, Satasuk Joy, et al.
Publicado: (2012)

Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2016)

Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison
por: Pinsent, Amy, et al.
Publicado: (2017)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
por: Liu, Fengchen, et al.
Publicado: (2013)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
por: Liu, Fengchen, et al.
Publicado: (2013)

Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program
por: Pant, Bidya Prasad, et al.
Publicado: (2016)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Forecasting Trachoma Control and Identifying Transmission-Hotspots
por: Blumberg, Seth, et al.
Publicado: (2021)

Eliminating Trachoma in Areas with Limited Disease
por: Gaynor, Bruce D., et al.
Publicado: (2003)

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II)
por: Keenan, Jeremy D., et al.
Publicado: (2018)

Elimination and Eradication of Neglected Tropical Diseases with Mass Drug Administrations: A Survey of Experts
por: Keenan, Jeremy D., et al.
Publicado: (2013)

Implications of the COVID-19 pandemic on eliminating trachoma as a public health problem
por: Blumberg, Seth, et al.
Publicado: (2020)

Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
por: Blumberg, Seth, et al.
Publicado: (2021)

Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
por: Borlase, Anna, et al.
Publicado: (2021)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Can we eradicate trachoma? A survey of stakeholders
por: Oldenburg, Catherine E, et al.
Publicado: (2021)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8j6mr8gs7bsrrdb0o1ot2turg7